Discovery of potential targets of Triptolide through inverse docking in ovarian cancer cells
Triptolide (TPL) is proposed as an effective anticancer agent known for its anti-proliferation of a variety of cancer cells including ovarian cancer cells. Although some studies have been conducted, the mechanism by which TPL acts on ovarian cancer remains to be clearly described. Herein, systematic...
Main Authors: | Qinhang Wu, Gang Bao, Yang Pan, Xiaoqi Qian, Furong Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2020-03-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/8620.pdf |
Similar Items
-
Identification of a binding target of triptolide and related studies
by: Zhao, Qian, et al.
Published: (2013) -
Renal-targeted delivery of triptolide by entrapment in pegylated TRX-20-modified liposomes
by: Yuan Z, et al.
Published: (2017-08-01) -
Advances on Effects of Triptolide with Non-small Cell Lung Cancer
by: Li WANG, et al.
Published: (2013-07-01) -
Palliative effects of metformin on testicular damage induced by triptolide in male rats
by: Ke Wang, et al.
Published: (2021-10-01) -
Synergistic antitumour effects of triptolide plus 10-hydroxycamptothecin onbladder cancer
by: Tianen Wang, et al.
Published: (2019-07-01)